A Phase IB Trial of Intravenous INO-1001 Plus Oral Temozolomide in Subjects with Unresectable Stage-III or IV Melanoma

By Bedikian Agop   Papadopoulos Nicholas   Kim Kevin   Hwu Wen-Jen   Homsi Jade   Glass Michelle   Cain Suzanne   Rudewicz Patrick   Vernillet Laurent   Hwu Patrick  

Cancer Investigation, Vol. 27, Iss. 7, 2009-08 ,pp. : 756-763

Informa Healthcare

Access to resources Recommend Favorite

A phase 2, multicenter, open‐label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma

By  

Cancer Medicine, Vol. 4, Iss. 5, 2015-05 ,pp. : 643-650

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stage IV Melanoma: Completely Resectable Patients are Scarce

By Wevers K.   Hoekstra H.  

Annals of Surgical Oncology, Vol. 20, Iss. 7, 2013-07 ,pp. : 2352-2356

Springer Publishing Company

Access to resources Recommend Favorite

Stage-IV Melanoma and Pulmonary Metastases: Factors Predictive of Survival

By Neuman Heather  

Annals of Surgical Oncology, Vol. 14, Iss. 10, 2007-10 ,pp. : 2847-2853

Springer Publishing Company

Access to resources Recommend Favorite

Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients

By Atzpodien Jens   Morawek Lars   Fluck Michael   Reitz Martina  

Cancer Chemotherapy and Pharmacology, Vol. 64, Iss. 5, 2009-10 ,pp. : 901-905

Springer Publishing Company

Access to resources Recommend Favorite